Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents

Evangelos C. Rizos; Georgia Salanti; Dimitrios P. Kontoyiannis; John P A Ioannidis

doi:10.1016/j.jclinepi.2010.11.017

Related publications

Preprint2021

Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials

Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, Isaac Dreyfus, Hessam Kakavand, Hamid Ariannejad, Aakriti Gupta, Mahesh V. Madhavan, Benjamín W. Van Tassell, David González Jiménez, Manuel Monréal, Muthiah Vaduganathan, John Fanikos, Dave L. Dixon, Gregory Piazza, Sahil A. Parikh, Deepak L. Bhatt, Professor Gregory Lip, Gregg W. Stone, Harlan M. Krumholz, Peter Libby, Samuel Z. Goldhaber, Behnood Bikdeli

Article2024

Stand age-related effects of mangrove on archaeal methanogenesis in sediments: Community assembly and co-occurrence patterns

Lingfang Ni, Jiaping Wu, Hongyue Dang, Carlos M. Duarte, Kai Feng, Ye Deng, Dao-Qiong Zheng, Dongdong Zhang

Article2014

Sydnone Sulfonamide Derivatives as Antibacterial, Antifungal, Antiproliferative and Anti-HIV Agents

Shahrukh T. Asundaria, Christophe Pannecouque, De Clercq Erik, Keshav Patel

Article1991

Analysis of co-occurrence in a fungal community

David A. Wardle, D. Parkinson

Mycological Research

Letter2009

Adverse Events in Randomized Trials

John P A Ioannidis